2013...
This presentation is the property of its rightful owner.
Sponsored Links
1 / 9

Николай Демидов, Генеральный директор IMS Health Россия и СНГ PowerPoint PPT Presentation


  • 243 Views
  • Uploaded on
  • Presentation posted in: General

«Тревожные сигналы для российского фармрынка летом 2013 года: дальше хуже или дальше только лучше?». Николай Демидов, Генеральный директор IMS Health Россия и СНГ. Общий прогноз развития мирового рынка был снижен (сентябрь) из-за корректировки прогноза по развивающимся рынкам.

Download Presentation

Николай Демидов, Генеральный директор IMS Health Россия и СНГ

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Ims health

2013 : ?

,

IMS Health


Ims health

() -

Global Sales and Growth, updated Sept 2013

US$ sales

Bn.

Growth

$1.2 trillion

1.200

10%

9%

1.000

8%

7%

800

6%

600

5%

4%

400

3%

2%

200

1%

0

0%

2008

2009

2010

2011

2012

2013 (f)

2014 (f)

2015 (f)

2016 (f)

2017 (f)

Source: IMS Health Market Prognosis, update September 2013, at ex-manufacturer price levels, not including rebates and discounts.

Moscow, 10th of December 2013


Ims health

Forecasted Sales and Growth

Sales US$ bn

Growth

75

8%

7,3%

6,7%

6,2%

6,2%

60

5,7%

6%

5,2%

45

4%

30

2%

15

0

0%

2012

2013

2014

2015

2016

2017

Russia + CIS

Balkans

CEE

Growth

Adriatics

Source: IMS Health Market Prognosis, Sep 2013, at ex-manufacturer price levels, not including rebates and discounts.

Moscow, 10th of December 2013


Ims health

:

110%

103%

103%

  • .

  • 1-3 . 2013?

Source: Rosstat

Moscow, 10th of December 2013


Ims health

Macroeconomic indexes in Russia: an emergency break in the middle of 2013 provides concerns

Key assumption

  • Macroeconomic slow down had still low effect on key social (consumer) indexes

  • The effect could be expected in the 4th quarter for retail and in the beginning of 2014 for state funded segments

Source: Rosstat

Moscow, 10th of December 2013


Ims health

Pharma market growth in Jan-Sept 2013

Retail sector continued to drive the market

Value

Volume

+7%

-4%

473,2

3,74

3,60

443,4

-3%

316,6

12%

283,7

SALES BY VOLUME, BLN PACKS

Retail

3,19

3,11

SALES BY VALUE, RUB BLN

Hospital

-11%

Reimbursement

-10%

83,1

92,7

-5%

0,47

73,5

0,42

10%

67,0

0,08

0,07

YTDQ3 2012

YTDQ3 2013

YTDQ3 2012

YTDQ3 2013

Source: IMS Health. TRD prices

Moscow, 10th of December 2013


Ims health

The market slowdown was firstly perceived as a remission after a high growth due to the Flu epidemic

Flu epidemic

comments

2012

  • Flu epidemic was the market driver in Q1: +19% (USD)

  • The growth reduction slowed the market down in Q2 to the critical +10%

  • 2013 Q3 shows unusual pattern of growth, compared to 2011 & 2012, with sales increase in July but flat sales in August (typical start of the season)

2013

2011

Growth

YvY 0!

Source: IMS Health.*-data atTRD prices

Moscow, 10th of December 2013


Ims health

:

Structural shift and price increaseof Non-EDL drive retail market

Rx

10,7%

3,0%

  • The shift of consumption structurehas significant impact on both EDL and Non EDLsegments

  • Price increase comes from Non EDL segment only

  • Structure shift is the only driver in EDL for a long time

    • Price growth on non-EDL products has probably a limited potential as a tool for margins increase for market players due to competition

10%

0,8%

1,5%

0,1%

Price

Structure

Volume

New products*

Total Growth

OTC

7,1%

13%

1,4%

3,6%

7,9%

0,0%

Price

Structure

Volume

New products*

Total Growth

Source: IMS Health. Data at TRD prices, Drop-out products are excluded due to low figures

Moscow, 10th of December 2013


Ims health

Long term forecast

Navigating different alternatives we are positive about attractiveness of the Russian market

CAGR Retail

+12.7%

Drug

insurance

CAGR %(2007-17)13.7%

Total Pharmaceutical market Sales

LC$B (ex-mnf), 2006-2017

Drivers

  • Price increases for products not included in the EDL will drive price growth in the retail market

  • Introduction of Drug insurance in a mid/long term range

New pricing system 2010

10%

Crisis2009

Regionalisation of DLO

18%

Constraints

  • Slow economy recovery

  • EDL pricing/ Restrictions on price registrations

  • An investigation into state procurement and changes to the state procurement rules could result in lower prices in the DLO and hospital sectors

2006

2007

2008

2009

2010

2011

2012

2013E

2014E

2015E

2016E

2017E

Source: IMS Health, Market Prognosis Sept 2013

Moscow, 10th of December 2013


  • Login